The abstract provided an alternative strategy to develop highly efficient and safe gadolinium-based MRI macromolecular contrast agents (Gd-mCAs) via conjugation of small molecular DOTA-Gd to a stimuli-responsive biodegradable and amphiphilic block DHPMA copolymer through a ROX-sensitive biocleavable disulfide bond. Also, its potential as efficient and safe MRI mCAs for cancer diagnosis have been investigated.
This abstract and the presentation materials are available to members only; a login is required.